Nature Reviews Drug Discovery, Published online: 18 June 2026; doi:10.1038/d41573-026-00106-5 A growing pipeline of multispecific antibody therapies are in clinical trials, showcasing novel biological effects as well as potential improvements over multi-agent cocktails.

Can multispecific biologics break the efficacy ceiling?
Asher Mullard
